305 related articles for article (PubMed ID: 28877978)
1. How I manage pulmonary Langerhans cell histiocytosis.
Lorillon G; Tazi A
Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877978
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.
Grobost V; Khouatra C; Lazor R; Cordier JF; Cottin V
Orphanet J Rare Dis; 2014 Nov; 9():191. PubMed ID: 25433492
[TBL] [Abstract][Full Text] [Related]
3. Current understanding and management of pulmonary Langerhans cell histiocytosis.
Vassallo R; Harari S; Tazi A
Thorax; 2017 Oct; 72(10):937-945. PubMed ID: 28689173
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary manifestations of Langerhans cell histiocytosis].
Obert J; Tazi A
Rev Mal Respir; 2015 Oct; 32(8):850-66. PubMed ID: 26003197
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Langerhans Cell Histiocytosis.
Shaw B; Borchers M; Zander D; Gupta N
Semin Respir Crit Care Med; 2020 Apr; 41(2):269-279. PubMed ID: 32279297
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Langerhans cell histiocytosis - an update on pathogenesis and treatment.
Jouenne F; Benattia A; Tazi A
Curr Opin Pulm Med; 2023 Sep; 29(5):451-458. PubMed ID: 37410483
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Langerhans Cell Histiocytosis: An Update From the Pathologists' Perspective.
Roden AC; Yi ES
Arch Pathol Lab Med; 2016 Mar; 140(3):230-40. PubMed ID: 26927717
[TBL] [Abstract][Full Text] [Related]
8. Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease.
Kamionek M; Ahmadi Moghaddam P; Sakhdari A; Kovach AE; Welch M; Meng X; Dresser K; Tomaszewicz K; Cosar EF; Mark EJ; Fraire AE; Hutchinson L
Histopathology; 2016 Sep; 69(3):499-509. PubMed ID: 26915300
[TBL] [Abstract][Full Text] [Related]
9. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases.
Roden AC; Hu X; Kip S; Parrilla Castellar ER; Rumilla KM; Vrana JA; Vassallo R; Ryu JH; Yi ES
Am J Surg Pathol; 2014 Apr; 38(4):548-51. PubMed ID: 24625419
[TBL] [Abstract][Full Text] [Related]
10. Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAF
Kambouchner M; Emile JF; Copin MC; Coulomb-Lherminé A; Sabourin JC; Della Valle V; Sileo C; Ducou Le Pointe H; Bégueret H; Galmiche L; Lambilliotte A; Paraf F; Piche M; Piguet C; Rullier A; Secq V; Serre I; Bernaudin JF; Donadieu J
Hum Pathol; 2019 Jul; 89():51-61. PubMed ID: 31054893
[TBL] [Abstract][Full Text] [Related]
11. New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis.
Torre O; Elia D; Caminati A; Harari S
Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954765
[TBL] [Abstract][Full Text] [Related]
12. Genetic landscape of adult Langerhans cell histiocytosis with lung involvement.
Jouenne F; Chevret S; Bugnet E; Clappier E; Lorillon G; Meignin V; Sadoux A; Cohen S; Haziot A; How-Kit A; Kannengiesser C; Lebbé C; Gossot D; Mourah S; Tazi A
Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 31806714
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and BRAF
Huo Z; Lu T; Liang Z; Ping F; Shen J; Lu J; Ma W; Zhao D; Zhong D
Diagn Pathol; 2016 Oct; 11(1):100. PubMed ID: 27760550
[TBL] [Abstract][Full Text] [Related]
14. Langerhans Cell Histiocytosis and Other Histiocytic Diseases of the Lung.
DeMartino E; Go RS; Vassallo R
Clin Chest Med; 2016 Sep; 37(3):421-30. PubMed ID: 27514589
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Langerhans' cell histiocytosis in adults.
Radzikowska E
Adv Respir Med; 2017; 85(5):277-289. PubMed ID: 29083024
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Multifocal Multisystem BRAF Positive Langerhans Cell Histiocytosis with Cladribine, Surgery and Allogenic Stem Cell Transplantation.
Gabalec F; Šimkovič M; Zavřelová A; Kašparová P; Morávková P; Kopáčová M; Masopust V; Žák P; Čáp J; Radocha J
Acta Medica (Hradec Kralove); 2017; 60(4):152-156. PubMed ID: 29716681
[TBL] [Abstract][Full Text] [Related]
17. Progress towards molecular-based management of childhood Langerhans cell histiocytosis.
Héritier S; Emile JF; Hélias-Rodzewicz Z; Donadieu J
Arch Pediatr; 2019 Jul; 26(5):301-307. PubMed ID: 31281037
[TBL] [Abstract][Full Text] [Related]
18. MAPK mutations and cigarette smoke promote the pathogenesis of pulmonary Langerhans cell histiocytosis.
Liu H; Osterburg AR; Flury J; Swank Z; McGraw DW; Gupta N; Wikenheiser-Brokamp KA; Kumar A; Tazi A; Inoue Y; Hirose M; McCormack FX; Borchers MT
JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31961828
[TBL] [Abstract][Full Text] [Related]
19. Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis.
Goyal G; Abeykoon JP; Hu M; Young JR; Shah MV; Bennani NN; Call TG; Hook CC; Pardanani A; Inwards DJ; Vassallo R; Ryu JH; Tobin WO; Koster MJ; Davidge-Pitts CJ; Ravindran A; Rech KL; Go RS;
Am J Hematol; 2021 May; 96(5):E146-E150. PubMed ID: 33539584
[No Abstract] [Full Text] [Related]
20. Clinical analysis for 15 patients with pulmonary Langerhans cell histiocytosis and literature review.
Zhang L; Ouyang R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):334-343. PubMed ID: 35545326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
